Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Infection: early-phase trial registry
10 of 45 indexed Infection trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #323 of 28,707 conditions by registered trial count.
45 US clinical trials · 10 currently recruiting · #323 of 28,707 conditions by registered trial count
Infection: 45 US clinical trials tracked, 10 recruiting.
Infection is the subject of 45 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 4 of these trials.
Enrollment posture brief
Registry condition infection
OPEN 10 | RECR 22% | LATE 5 | EARLY 10 | RANK #323 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Acne (22% recruiting · 27 trials)
Infection lists 10 open slots (22% of 45 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Infection is recruiting below its size-band peers.
10 of 45 indexed trials (22.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Infection trials is spread across many organizations.
Brigham and Women's Hospital accounts for 4 of 45 trials (8.9%). 36 distinct sponsors appear on at least one study for this condition label.
-
Typical Infection enrolment sits around 172 participants.
Median target enrolment is 172 among the 42 trials that report a genuine target (sentinel values excluded). 16 of those (38.1%) plan for fewer than 100 participants.
-
Infection splits between interventional and observational designs.
30 interventional and 15 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
45 total, page 1 of 1
Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection
Trustees of Dartmouth College
NCT04600973
Biomarkers in Infection
Beth Israel Deaconess Medical Center
NCT02545478
Home Hospital for Suddenly Ill Adults
Brigham and Women's Hospital
NCT03524222
Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Karius
NCT07110636
Diagnosis and Management of Inflammatory and Infectious Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00557726
Persona Revision Knee System Outcomes
Zimmer Biomet
NCT04821154
BLOOM: Pragmatic Feasibility Trial
Mayo Clinic
NCT07287332
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
University of Colorado, Denver
NCT02299921
Copper Supplementation in Cirrhosis
University of Washington
NCT07471542
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
National Institute of Allergy and Infectious Diseases (NIAID)
NCT05189925
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
National Eye Institute (NEI)
NCT00116090
Evaluation of the Heparin Binding Protein Levels in Sepsis
Christiana Care Health Services
NCT02533011
Early Identification of SEPsis SIGNs in Emergency Department
BioMérieux
NCT04261621
Antibiotic Prophylaxis for Transrectal Prostate Biopsy
Northwestern University
NCT01659866
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
Innocoll
NCT02447172
A Retrospective Review of Infections Usually Observed in Transplant Recipients
University of Pittsburgh
NCT00298077
Evaluation of Infection in Obstructing Urolithiasis
University of Texas Southwestern Medical Center
NCT04332861
Timing of Antibiotic Prophylaxis for Cesarean Deliveries
University of Florida
NCT00805545
Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care
Penn State University
NCT00127699
Retrospective Analysis of Clinical Features in Ventriculoperitoneal Shunt Infectionsin Adults
University of Pittsburgh
NCT00524108
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Ocean Spray Cranberries
NCT01776021
MAKE IT CLEAN, Impact of Pocket Revision on the Rate of Infection and Other Complications in Patients Requiring Pocket Manipulation for Generator Replacement and/or Lead Replacement or Revision: A Prospective Randomized Study
Dhanunjaya Lakkireddy, MD, FACC
NCT00599261
Remote Physician Care for Home Hospital Patients
Brigham and Women's Hospital
NCT04080570
Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children
Virginia Commonwealth University
NCT00308906
Antibiotic Prophylaxis Before Percutaneous Gastrostomy
University of Washington
NCT01424085
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
Carelon Research
NCT00627393
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
University of Pittsburgh
NCT00363220
Decreasing Infection In Arthroscopic Shoulder Surgery
McLaren Health Care
NCT02219776
Longitudinal Gene Expression Profiling in Adults After Traumatic Injury
Stanford University
NCT02656459
Clinical Experiment of Helicobacter Pylori Transmission
Stanford University
NCT00550368
CleanHands Sensor Based System to Improve Hand Hygiene and Reduce Infection
Microsensor Labs
NCT03948672
Bioequivalency Study of Clarithromycin Tablets Under Fasting Conditions
Roxane Laboratories
NCT00601315
Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
M.D. Anderson Cancer Center
NCT01321879
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
City of Hope Medical Center
NCT00589563
Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects
Cadence Pharmaceuticals
NCT00608959
Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX
B. Braun Medical
NCT01121354
Interactions of Environmental and Human Microbial Communities in a Pediatric Oncology Hospital
St. Jude Children's Research Hospital
NCT02948335
Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration
Mayo Clinic
NCT04673877
Community Central Line Infection Prevention Trial
Johns Hopkins University
NCT02351258
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
PluroGen Therapeutics
NCT02119754
Rural Home Hospital: Proof of Concept
Brigham and Women's Hospital
NCT04531280
Personalized Immunotherapeutic for Antibiotic-resistant Infection
Brigham and Women's Hospital
NCT02508584
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
Roswell Park Cancer Institute
NCT00022035
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
NCT00064311
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
University of Maryland, Baltimore
NCT00046852
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 3 |
| Phase 3 | 3 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Infection page
45 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Brigham and Women's Hospital sponsors the most Infection trials on record, review their full trial history before evaluating a specific study. See Brigham and Women's Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infection condition card totals 45 registered trials; most-linked intervention Usual Care; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.